Privately-held StemBioSys, Inc., based in San Antonio, closed on a fully subscribed $8 million Series A Preferred Stock financing on April 1st, 2015. According to StemBioSys CEO Bob Hutchens, the company is investing the proceeds primarily in a GMP manufacturing facility and market preparations for a mid-2015 launch of its proprietary and novel advanced stem cell culture system -- HPMETM -- for sale in the stem cell research market.
http://ift.tt/1FSk3oe
http://ift.tt/1FSk3oe
No comments:
Post a Comment